Brett Taylor
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Brett Taylor has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Brandon M. Jones
Department of Medicine, University of California , San Diego, California
1 shared publication - Clark Wang
Department of Medicine, University of California , San Diego, California
1 shared publication - Daisuke Kawauchi
Department of Neurosurgery and Neuro-Oncology, National Cancer Center Hospital, Tokyo, Japan
1 shared publication Emilie C. B. Desclos
Department of Medical Biology, Amsterdam University Medical Centers, Amsterdam, The Netherlands
1 shared publication- Fabio Vanoli
Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
1 shared publication - Florian Morati
Department of Life Sciences, Chalmers University of Technology, Gothenburg, Sweden
1 shared publication
Latest Publications
- Open Access
- 28 September 2026
- Published by Oxford University Press (OUP) in Neuro-Oncology
SNP rs2853669 potentially elevates the risk of glioblastoma development and leads to worse prognosis when in cis with mutant telomerase reverse transcriptase promoter in a Japanese cohort
Background: Mutations in the telomerase reverse transcriptase (TERT) promoter region (TPM), particularly C228T and C250T, are common in IDH-wildtype glioblastoma (GBM). The single nucleotide polymorphism (SNP) rs2853669, also located in the TERT promoter, may influence telomerase activity, though its clinical relevance in GBM remains unclear. This study examined the allelic configuration between rs2853669 and TPM to elucidate their combined effects on TERT expression and clinical outcome. Methods: Seventy-six TPM-positive GBM tumors from Japanese patients were analyzed by nested PCR, and patients were classified by rs2853669 genotype (T/T, T/C, C/C). In the T/C subgroup, the allelic configuration between the SNP and TPM was determined as cis (same allele) or trans (different alleles). Clinical data, TERT expression, and prognosis were compared among groups. Results: Among 76 patients, 37 (48.7%) had T/T, 30 (39.5%) had T/C, and 9 (11.8%) had C/C genotypes. The rs2853669 C allele frequency was higher in GBM than in the general Japanese population (31.6% vs 24.5%, P = .047). Among T/C cases, 53.3% showed a cis configuration. Patients carrying the SNP and TPM on the same allele (C/C and T/C cis) had shorter overall survival than those carrying them on different alleles (T/T or T/C trans; 19 vs 25 months, P = .048), and TERT expression was also lower in this group (P = .038). Conclusion: The rs2853669 C allele may increase GBM susceptibility and, when in cis with TPM, is associated with reduced TERT expression and poorer prognosis, underscoring its biological and clinical significance in TPM-mutant GBM.
- 28 September 2026
- Published by Oxford University Press (OUP) in Neuro-Oncology
Open AccessSNP rs2853669 potentially elevates the risk of glioblastoma development and leads to worse prognosis when in cis with mutant telomerase reverse transcriptase promoter in a Japanese cohort
Background: Mutations in the telomerase reverse transcriptase (TERT) promoter region (TPM), particularly C228T and C250T, are common in IDH-wildtype glioblastoma (GBM). The single nucleotide polymorphism (SNP) rs2853669, also located in the TERT promoter, may influence telomerase activity, though its clinical relevance in GBM remains unclear. This study examined the allelic configuration between rs2853669 and TPM to elucidate their combined effects on TERT expression and clinical outcome. Methods: Seventy-six TPM-positive GBM tumors from Japanese patients were analyzed by nested PCR, and patients were classified by rs2853669 genotype (T/T, T/C, C/C). In the T/C subgroup, the allelic configuration between the SNP and TPM was determined as cis (same allele) or trans (different alleles). Clinical data, TERT expression, and prognosis were compared among groups. Results: Among 76 patients, 37 (48.7%) had T/T, 30 (39.5%) had T/C, and 9 (11.8%) had C/C genotypes. The rs2853669 C allele frequency was higher in GBM than in the general Japanese population (31.6% vs 24.5%, P = .047). Among T/C cases, 53.3% showed a cis configuration. Patients carrying the SNP and TPM on the same allele (C/C and T/C cis) had shorter overall survival than those carrying them on different alleles (T/T or T/C trans; 19 vs 25 months, P = .048), and TERT expression was also lower in this group (P = .038). Conclusion: The rs2853669 C allele may increase GBM susceptibility and, when in cis with TPM, is associated with reduced TERT expression and poorer prognosis, underscoring its biological and clinical significance in TPM-mutant GBM.
- Open Access
- 12 July 2021
- Published by Springer Nature in Nature Communications
- Vol. 12 (1) , 1-15
Distinct pathways of homologous recombination controlled by the SWS1–SWSAP1–SPIDR complex
Homology-directed repair (HDR), a critical DNA repair pathway in mammalian cells, is complex, leading to multiple outcomes with different impacts on genomic integrity. However, the factors that control these different outcomes are often not well understood. Here we show that SWS1–SWSAP1-SPIDR controls distinct types of HDR. Despite their requirement for stable assembly of RAD51 recombinase at DNA damage sites, these proteins are not essential for intra-chromosomal HDR, providing insight into why patients and mice with mutations are viable. However, SWS1–SWSAP1-SPIDR is critical for inter-homolog HDR, the first mitotic factor identified specifically for this function. Furthermore, SWS1–SWSAP1-SPIDR drives the high level of sister-chromatid exchange, promotes long-range loss of heterozygosity often involved with cancer initiation, and impels the poor growth of BLM helicase-deficient cells. The relevance of these genetic interactions is evident as SWSAP1 loss prolongs Blm-mutant embryo survival, suggesting a possible druggable target for the treatment of Bloom syndrome.
- 12 July 2021
- Published by Springer Nature in Nature Communications
- Vol. 12 (1) , 1-15
Open AccessDistinct pathways of homologous recombination controlled by the SWS1–SWSAP1–SPIDR complex
Homology-directed repair (HDR), a critical DNA repair pathway in mammalian cells, is complex, leading to multiple outcomes with different impacts on genomic integrity. However, the factors that control these different outcomes are often not well understood. Here we show that SWS1–SWSAP1-SPIDR controls distinct types of HDR. Despite their requirement for stable assembly of RAD51 recombinase at DNA damage sites, these proteins are not essential for intra-chromosomal HDR, providing insight into why patients and mice with mutations are viable. However, SWS1–SWSAP1-SPIDR is critical for inter-homolog HDR, the first mitotic factor identified specifically for this function. Furthermore, SWS1–SWSAP1-SPIDR drives the high level of sister-chromatid exchange, promotes long-range loss of heterozygosity often involved with cancer initiation, and impels the poor growth of BLM helicase-deficient cells. The relevance of these genetic interactions is evident as SWSAP1 loss prolongs Blm-mutant embryo survival, suggesting a possible druggable target for the treatment of Bloom syndrome.
- Open Access
- 12 April 2019
- Published by International Union of Crystallography (IUCr) in IUCrData
- Vol. 4 (4) , x190478
The crystal structure of 2-[(tert-butyldiphenylsilyl)oxy]-1,2-diphenylethan-1-one
The title compound, C30H30O2Si, was synthesized and structurally characterized in order to determine the influence of the bulky silyl protecting group on the conformation of the benzoin moiety, with a view to directing the stereochemistry of the borohydride reduction of the benzoin. The crystal structure shows a benzoin O—C—C—O torsion angle of 38.34 (1)°, not greatly different from that found in benzoin itself. In the crystal, a weak C—H...O hydrogen bond between the carbonyl group and a phenyl H atom of a symmetry-related molecule forms chains along [100].
- 12 April 2019
- Published by International Union of Crystallography (IUCr) in IUCrData
- Vol. 4 (4) , x190478
Open AccessThe crystal structure of 2-[(tert-butyldiphenylsilyl)oxy]-1,2-diphenylethan-1-one
The title compound, C30H30O2Si, was synthesized and structurally characterized in order to determine the influence of the bulky silyl protecting group on the conformation of the benzoin moiety, with a view to directing the stereochemistry of the borohydride reduction of the benzoin. The crystal structure shows a benzoin O—C—C—O torsion angle of 38.34 (1)°, not greatly different from that found in benzoin itself. In the crystal, a weak C—H...O hydrogen bond between the carbonyl group and a phenyl H atom of a symmetry-related molecule forms chains along [100].